生物假体门故障:在心交位置的管理策略
Khaled AlOtaiby1, Zakariya Albinmousa2, Sondos Samargandy3
1Adult Cardiac Surgery Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
JACC. Case reports
|October 31, 2025
概括
生物假体门的故障是一个越来越令人担忧的问题,特别是在复杂的患者. 这个病例显示了外科手术的关置换 (MVR),随后是透气管内 (ViV),最终由于严重化,需要重复手术.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 生物假体失效是一个日益严重的临床问题,特别是在患有并发病的年轻患者中.
- 过导管内 (ViV) 植入提供了重复手术的替代方案,但由于严重的化或感染,可能会失败.
研究的目的:
- 为了呈现一种渐进的生物假体中枢失效的病例.
- 为了说明从手术MVR到ViV植入和随后的重复手术的管理途径.
主要方法:
- 一个37岁的男性患有全身性红斑狼和末期脏疾病的病例报告.
- 这位患者之前接受过额头气置换 (MVR) 和通过导管的额头气内 (ViV) 植入.
- 评估复发的 mitrale 狭窄与严重的 mitrale 环状化和肺高血压.
主要成果:
- 患者在ViV植入后两年经历了重复重复的额叶狭窄症.
- 发现包括24mmHg的平均梯度,广泛的额头环状化和严重的肺高血压.
- 这就需要考虑进一步的干预.
结论:
- 生物假体失效是一个重大挑战,特别是在患有并发症和先前干预的患者中.
- 管理需要个性化,多学科的决策.
- 对于严重环状化或透气管后并发症的病例,重新进行手术至关重要.
相关概念视频
Mitral Stenosis III: Medical Management
237
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
237
Mitral Regurgitation III: Medical Management
264
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
264
Mitral Valve Prolapse II: Assessment and Management
399
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
399
Mitral Valve Prolapse I: Introduction
363
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
363
Mitral Regurgitation IV: Nursing Management
298
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
298
Mitral Valve Prolapse III: Nursing Management
277
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
277


